Many studies have demonstrated that ITGB2 is overexpressed in ovarian cancer relative to normal ovarian tissue; it is linked to metastasis and poor prognosis in ovarian cancer and can be used as a prognostic immunomarker [51]. The gene discussed is ITGB2; the disease is ovarian cancer.